Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$60.6M |
| 2 |
CoStar Group
CSGP
|
+$57.8M |
| 3 |
Consolidated Edison
ED
|
+$52.3M |
| 4 |
Deere & Co
DE
|
+$44.5M |
| 5 |
Exelon
EXC
|
+$42.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Amazon
AMZN
|
+$366M |
| 3 |
Moderna
MRNA
|
+$123M |
| 4 |
Entergy
ETR
|
+$44.9M |
| 5 |
Linde
LIN
|
+$43.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.98% |
| 2 | Industrials | 10.54% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Financials | 9.11% |
| 5 | Healthcare | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Target
TGT
$77.2B
| $806K | 0.01% |
3,524
-21,148
| -86% | -$5.3M |
|
1127
Hudbay
HBM
$13.1B
| $805K | 0.01% |
+129,197
| New | +$818K |
|
1128
Corteva
CTVA
$55.3B
| $804K | 0.01% |
+19,095
| New | +$826K |
|
1129
Puma Biotechnology
PBYI
$471M
| $803K | 0.01% |
114,517
+74,186
| +184% | +$555K |
|
1130
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $802K | 0.01% |
8,500
-16,800
| -66% | -$1.6M |
|
1131
Oceaneering
OII
$5.02B
| $801K | 0.01% |
+60,158
| New | +$784K |
|
1132
iShares MSCI Singapore ETF
EWS
$1.22B
| $796K | 0.01% |
34,962
| – | – |
|
1133
Veeco
VECO
$2.86B
| $795K | 0.01% |
35,812
+8,801
| +33% | +$196K |
|
|
DRNA
1134
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $795K | 0.01% |
+39,453
| New | +$1.09M |
|
|
NATI
1135
DELISTED
National Instruments Corp
NATI
| $794K | 0.01% |
+20,235
| New | +$847K |
|
1136
GoPro
GPRO
$111M
| $793K | 0.01% |
84,686
+52,206
| +161% | +$528K |
|
1137
Columbus McKinnon
CMCO
$518M
| $792K | 0.01% |
16,388
-14,737
| -47% | -$667K |
|
1138
SM Energy
SM
$8.67B
| $792K | 0.01% |
30,014
-18,997
| -39% | -$384K |
|
1139
Honda
HMC
$42.3B
| $791K | 0.01% |
+25,805
| New | +$812K |
|
1140
Lakeland Financial Corp
LKFN
$1.5B
| $790K | 0.01% |
11,085
-28,070
| -72% | -$1.83M |
|
1141
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.92B
| $789K | 0.01% |
4,754
+2,989
| +169% | +$511K |
|
1142
Healthcare Services Group
HCSG
$1.56B
| $789K | 0.01% |
+31,584
| New | +$854K |
|
|
SASR
1143
DELISTED
Sandy Spring Bancorp Inc
SASR
| $789K | 0.01% |
17,209
-10,085
| -37% | -$432K |
|
1144
LCI Industries
LCII
$2.54B
| $788K | 0.01% |
5,856
-3,665
| -38% | -$506K |
|
1145
Smith & Nephew
SNN
$12.4B
| $788K | 0.01% |
+22,950
| New | +$904K |
|
|
QADA
1146
DELISTED
QAD Inc.
QADA
| $786K | 0.01% |
8,996
+5,117
| +132% | +$446K |
|
1147
AngloGold Ashanti
AU
$60.9B
| $782K | 0.01% |
+48,925
| New | +$847K |
|
1148
Invesco Next Gen Media and Gaming ETF
GGME
$44.6M
| $782K | 0.01% |
14,577
+10,724
| +278% | +$577K |
|
1149
Full Truck Alliance
YMM
$8.75B
| $781K | 0.01% |
50,978
+20,378
| +67% | +$300K |
|
1150
EverQuote
EVER
$938M
| $779K | 0.01% |
+41,835
| New | +$1M |
|
Similar funds
Michael Gelband's Q3 2021 Portfolio in Review
As of Q3 2021, Michael Gelband held 2,951 positions worth $7.41B, down 18% from $9.04B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Michael Gelband withdrew a net $1.27B in Q3 2021, closing 919 positions and reducing 594 holdings. Its most notable exit was Amazon, an estimated $366M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Michael Gelband opened a new position in Advanced Micro Devices worth $61M.
- Michael Gelband's largest Q3 2021 buy was Advanced Micro Devices: 592,990 shares worth $61M.
- Michael Gelband added most to CoStar Group in Q3 2021, an estimated $57.8M increase.
- Michael Gelband's biggest Q3 2021 reduction was Microsoft, cutting an estimated $483M.
- Michael Gelband fully exited Amazon in Q3 2021, selling an estimated $366M.
- Michael Gelband's ten largest holdings make up 9.8% of its $7.41B portfolio in Q3 2021.
- Michael Gelband opened 679 new positions and closed 919 in Q3 2021.
- Michael Gelband's portfolio value fell 18% quarter-over-quarter to $7.41B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.